About this Event
This meeting will focus on key developments in regulatory and policy matters, and international business opportunities, bringing together insights from across the sector.
Key agenda items include the below, and a final meeting agenda and paper will be shared before the meeting:
- Preparing for regulatory inspections
- Policy and program updates from the Office of Research and Innovation (ORI)
- Insights on international business opportunities in UK
- Advancements in Queensland’s clinical trials ecosystem:
- Australian Teletrial Program
- New Clinical Trials Hub
- Future directions for the Queensland Clinical Trials Consortium
Chaired by:
- Melissa Hagan, QCTCU Director, Office of Research and Innovation, Queensland Health
Presentations from:
- David Liteplo, Head of Quality Assurance, Pharma Services, Thermo Fisher Scientific
- Prof Julie White, Executive Director, Office of Research and Innovation, Queensland Health
- Prof Chris Molloy, CEO, Medicines Discovery Catapult, UK
- Dr Helen Breathnach, Senior Manager, Research Facilitation, Health Translation Queensland
- Sara Gottliebsen, Research Governance Manager, Health Translation Queensland
- Melanie Poxton, Assistant Director of Nursing, Queensland Regional Clinical Trial Coordinating Centre (QRCCC), Office of Research and Innovation, Queensland Health
Please register your in-person attendance by 15 November.
We look forward to your valuable contribution to discussions on the day and shaping the future of life sciences in Queensland.
ABOUT THE ORGANISER:
This event is proudly brought to you by:
Queensland Health provides a range of services aimed at achieving good health and well-being for all Queenslanders.
www.health.qld.gov.au
Event Venue & Nearby Stays
111 George Street Auditorium, entry via either George Street or 33 Charlotte Street, CBD, Brisbane., 111 George Street, Brisbane City, Australia
AUD 0.00
